Data gathered: November 8
Alternative Data for McKesson
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 427 | Sign up | Sign up | Sign up |
| Sentiment | 76 | Sign up | Sign up | Sign up |
| Webpage traffic | 2,764,000 | Sign up | Sign up | Sign up |
| Employee Rating | 76 | Sign up | Sign up | Sign up |
| Google Trends | 72 | Sign up | Sign up | Sign up |
| Patents | 76 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 67 | Sign up | Sign up | Sign up |
| Facebook Followers | 27,674 | Sign up | Sign up | Sign up |
| Instagram Followers | 10,164 | Sign up | Sign up | Sign up |
| Reddit Mentions | 3 | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 20 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 3,609 | Sign up | Sign up | Sign up |
| Twitter Followers | 22,116 | Sign up | Sign up | Sign up |
| Twitter Mentions | 9 | Sign up | Sign up | Sign up |
| News Mentions | 1 | Sign up | Sign up | Sign up |
| Customer reviews | 40 | Sign up | Sign up | Sign up |
| Lobbying Cost | $227,000 | Sign up | Sign up | Sign up |
| Business Outlook | 69 | Sign up | Sign up | Sign up |
| Linkedin Employees | 21,725 | Sign up | Sign up | Sign up |
About McKesson
Incorporated in 1833, Texas-based McKesson Corp. provides pharmaceuticals, health information technology, medical supplies, and care management tools. The company operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions, International, and Medical-Surgical Solutions.
| Price | $614.42 |
| Target Price | Sign up |
| Volume | 244,560 |
| Market Cap | $71.2B |
| Year Range | $479.06 - $629.58 |
| Dividend Yield | 0.54% |
| PE Ratio | 23.47 |
| Analyst Rating | 86% buy |
| Industry | Digital health |
In the news
Baird Upgrades McKesson (MCK)November 7 - Fintel |
|
McKesson : Sell-Side Update PresentationNovember 7 - Finnhub |
|
McKesson Corp. stock outperforms competitors on strong trading dayNovember 7 - MarketWatch |
|
 |
MCK Stock Gains as Q2 Earnings & Sales Top Estimates, '25 EPS View UpNovember 7 - Yahoo |
McKesson Shares Jump After FY25 Outlook Boost, Strong 2Q SalesNovember 6 - MarketWatch |
|
 |
McKesson Corp (MCK) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ...November 6 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '24 | 79.3B | 78.2B | 3.15B | 915M | 1.18B | 7.880 |
| Q1 '24 | 76.3B | 75.4B | 3.59B | 791M | 1.66B | 6.180 |
| Q4 '23 | 80.8B | 80.3B | 3.15B | 589M | 697M | 7.740 |
| Q3 '23 | 77.2B | 76.3B | 3.07B | 664M | 1B | 6.230 |
| Q2 '23 | 74.4B | 73.4B | 3.02B | 958M | 1.16B | 7.270 |
Insider Transactions View All
| TYLER BRIAN S. filed to sell 78,586 shares at $561.1. September 6 '24 |
| TYLER BRIAN S. filed to sell 82,339 shares at $626. August 6 '24 |
| TYLER BRIAN S. filed to sell 86,092 shares at $580.9. July 8 '24 |
| Smith LeAnn B filed to sell 2,022 shares at $585.5. June 12 '24 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Teladoc HealthTDOC |
$9.36 1.6% | 51 |
 |
Veeva SystemsVEEV |
$237.47 6.3% | 48 |
 |
DoximityDOCS |
$58.93 35.7% | 63 |
 |
GoodRxGDRX |
$4.98 1.2% | 33 |
 |
Lifestance HealthLFST |
$7.41 3.5% | 63 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Ro Khanna |
Oct 8, 24 | Buy | $1K - $15K |
| Carol Miller Republican |
Jun 5, 24 | Sell | $15K - $50K |
| Carol Miller Republican |
Jun 5, 24 | Sell | $15K - $50K |
Read more about McKesson (MCK) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
What is the Market Cap of McKesson?
The Market Cap of McKesson is $71.2B.
What is McKesson's PE Ratio?
As of today, McKesson's PE (Price to Earnings) ratio is 23.47.
What is the current stock price of McKesson?
Currently, the price of one share of McKesson stock is $614.42.
How can I analyze the MCK stock price chart for investment decisions?
The MCK stock price chart above provides a comprehensive visual representation of McKesson's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling McKesson shares. Our platform offers an up-to-date MCK stock price chart, along with technical data analysis and alternative data insights.
Does MCK offer dividends to its shareholders?
Yes, McKesson (MCK) offers dividends to its shareholders, with a dividend yield of 0.54%. This dividend yield represents McKesson's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering McKesson in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of McKesson?
Some of the similar stocks of McKesson are Teladoc Health, Veeva Systems, Doximity, GoodRx, and Lifestance Health.
.